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ABSTRACT Previous work has shown that two molecules of a soluble form of phosphatidylserine, C6PS, bind to human and
bovine factor Xa. Activity measurements along with the ﬂuorescence of active-site-labeled human factor Xa showed that two
linked sites speciﬁcally regulate the active site conformation and proteolytic activity of the human enzyme. These results imply,
but cannot demonstrate, a C6PS-induced factor Xa conformational change. The purpose of this paper is to extend these
observations to bovine factor Xa and to demonstrate that they do reﬂect conformational changes. We report that the
ﬂuorescence of active-site-labeled bovine factor Xa also varied with C6PS concentration in a sigmoidal manner, whereas
amidolytic activity of unlabeled enzyme varied in a simple hyperbolic fashion, also as seen for human factor Xa. C6PS induced
a 70-fold increase in bovine factor Xa’s autolytic activity, consistent with the 60-fold increase in proteolytic activity reported for
human factor Xa. In addition, circular dichroism spectroscopy clearly demonstrated that C6PS binding to bovine factor Xa
induces secondary structural changes. In addition, C6PS binding to the tighter of the two sites triggered structural changes that
lead to Ca2þ-dependent dimer formation, as demonstrated by changes in intrinsic ﬂuorescence and quantitative native gel
electrophoresis. Dimerization produced further change in secondary structure, either inter- or intramolecularly. These results,
along with results presented previously, support a model in which C6PS binds in a roughly sequential fashion to two linked sites
whose occupancy in both human and bovine factor Xa elicits different structural and functional responses.
INTRODUCTION
The activation of prothrombin to thrombin is a crucial step in
the blood coagulation process. It is accomplished by the
prothrombinase complex, which consists of a serine pro-
tease, factor Xa, and a protein cofactor, factor Va, interacting
on an appropriate acidic membrane surface (Jackson and
Nemerson, 1980; Mann et al., 1990). When compared with
factor Xa in the presence of factor Va in solution, the ac-
tivation of prothrombin to thrombin by the prothrombinase
complex on an appropriate phospholipid membrane surface
is enhanced;1000-fold (Nesheim et al., 1979; Rosing et al.,
1980). Activated platelets (Kane et al., 1980; Tracy and
Mann, 1986) or other cells of the circulatory system (Tracy,
1988; Tracy et al., 1985) can provide the active surface.
Several studies (Comfurius et al., 1994; Jones et al., 1985;
Rosing et al., 1988) have shown that PS specifically
enhances prothrombin activation. We now know that this
is due to specific regulatory sites on factors Xa and Va
(Banerjee et al., 2002a; Koppaka et al., 1996; Srivastava
et al., 2002; Zhai et al., 2002).
Binding of human factor Xa to a membrane seems to
involve two to four molecules of membrane-associated PS
(Cutsforth et al., 1989). A soluble form of PS, C6PS, binds
human factor Xa in solution (Koppaka et al., 1996). Two
C6PS molecules bind to either human or bovine factor Xa,
one to a pair of epidermal-growth-factor-like domains
(EGFNC) when these are linked to an N-terminal g-car-
boxy-glutamic-acid-rich domain, and one to the catalytic
domain (Srivastava et al., 2002). The EGFNC site (site 1),
located near the membrane surface, alters the catalytic
domain at the other end of human factor Xa, including the
affinity of the C6PS site in this domain (site 2) (Banerjee
et al., 2002a). Binding of C6PS to the catalytic domain
is anomalous and appears to involve part of the substrate
recognition site (Srivastava et al., 2002). C6PS binding
increases human factor Xa’s kcat in prothrombin activation
by 60-fold (Koppaka et al., 1996), with activity seemingly
regulated principally by site 1 (Banerjee et al., 2002a). Site 1
is Ca2þ-dependent but not Ca2þ- requiring (Srivastava et al.,
2002) and minimally binds DAG as a ligand, but requires
C6PS to affect activity (Banerjee et al., 2002a). Site 2
requires Ca2þ (Srivastava et al., 2002), and its minimal
ligand is GPS (Banerjee et al., 2002a). It can be occupied
by acidic lipids other than PS, but not by neutral lipids
(Banerjee et al., 2002a; Srivastava et al., 2002).
PS-containing synthetic membranes have been shown to
alter the conformation of prothrombinase complex compo-
nents. The conformation of prothrombin clearly is altered on
binding to a PS-containing membrane (Chen and Lentz,
1997). Binding of C6PS alters both the structure and cofactor
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activity of factor Va (Zhai et al., 2002), such that a fully
active prothrombinase is formed in solution when factors Va
and Xa are incubated in the presence of C6PS (Majumder
et al., 2002). One paper reported a possible effect of PS-
containing membranes on factor Xa structure by virtue of
a change in fluorescence of an active site label, dansyl-Glu-
Gly-Arg-chloromethyl ketone (DEGR) (Husten et al., 1987).
We have used the fluorescence of DEGR-Xa to follow
binding of different soluble phospholipids, with the in-
ference that different changes in fluorescence reflect differ-
ent structural changes (Banerjee et al., 2002a). Changes in
DEGR-Xa fluorescence in response to C6PS have been
interpreted in terms of a model that assumes that occupancy
of each of the two sites produces different structural changes
(Banerjee et al., 2002a). However, this change in fluores-
cence of an active-site probe is suggestive of but cannot
prove that C6PS induces a conformational change in factor
Xa, so we report here additional experiments that demon-
strate a C6PS-induced conformational change. Specifically,
we show: 1), that PS-specific changes in bovine factor Xa
secondarystructure accompanysolublephospholipidbinding;
2), that occupancy of the two sites seems to produce differ-
ent structural responses; 3), that conformational changes
associated with occupancy of site 1 lead, in a Ca2þ-
dependent fashion, to factor Xa dimerization in solution;
and 4), that changes in the autolytic activity of bovine
factor Xa parallel proteolytic activity changes reported for
human factor Xa (Banerjee et al., 2002a; Koppaka et al.,
1996).
MATERIALS
DEGR-CK was purchased from Calbiochem (La Jolla, CA). C6PC, C6PG,
C6PS, DOPG, POPC, and bovine brain PS were purchased from Avanti
Polar Lipids (Alabaster, AL). Factor Xa-specific substrate S2765 was
purchased from Helena Laboratories (Beaumont, TX). All other chemicals
were ACS reagent grade or the best available grade.
METHODS
Short-chain phospholipid preparation
Chloroform was removed from measured amounts of C6PS, C6PG, and
C6PC stocks using a stream of nitrogen, and the lipid samples were
dissolved in cyclohexane and lyophilized overnight. The lyophilized lipids
were then suspended in an appropriate amount of buffer A (50 mM Tris, 0.1
M NaCl, pH 7.5) to reach desired concentrations.
Vesicle preparation
Large unilamellar extrusion vesicles were prepared by the method of
Hope et al. (1985). Dried lipid samples were suspended above their phase
transition temperatures in an appropriate amount of buffer A to reach a
concentration of roughly 15 mM. The vesicles were then extruded
seven times, above their phase transition temperature and under pressure
(50–60 psi of Ar), through a 0.1-mm polycarbonate filter (Nucleopore,
Pleasanton, CA).
Factor X isolation and activation
Bovine factor X was isolated by barium citrate precipitation from freshly
collected bovine plasma (Mann, 1976; Tendian and Lentz, 1990). Factor X
obtained in this manner was analyzed by SDS-PAGE, concentrated
(Centricon-10 concentrator, Amicon Division, W.R. Grace, Danvers, MA)
and then stored at 708C at a concentration ;1 mg/ml. A final purification
step was performed one day before an experiment by dialyzing into low salt
buffer, loading onto a Mono Q HR 5/5 ion exchange column (Pharmacia,
Norwalk, CT), and eluting by high-performance liquid chromatography on
a Perkin-Elmer Isopure LC system using a linear NaCl gradient from 0 to
1M NaCl. The purified factor X was dialyzed into buffer A for activation.
Factor X was activated with a purified fraction of Russel’s viper venom
factor X activating protein (RVV-X; Hematological Technologies, Essex
Junction, VT) that had been covalently linked to Affigel-15 (Bio-Rad,
Hercules, CA) agarose beads (Jesty and Nemerson, 1976). The cleavage of
a single arginyl-isoleucine peptide bond in the heavy chain of factor X
results in the formation of factor Xaa. Factor Xaa is slowly degraded to give
rise to factor Xab (Fujikawa et al., 1974). The two forms of factor Xa
obtained were analyzed by SDS-PAGE on a 10% gel. A high concentration
of factor Xaa relative to factor Xabwas obtained for autolysis experiments by
controlling the time of factor X incubation with RVV beads. Sodium citrate
was then added to stop the reaction and the RVV beads were removed by
centrifugation. We performed a series of experiments to define the optimal
reaction time (25 min) to minimize the amounts of factor X and factor Xab
under our experimental conditions. Under these conditions, the final reaction
mixtures contained;85–90% factor Xaa, 5–10% factor X, and 2–5% factor
Xab as averaged from several preparations. The supernatant, containing
mainly factor Xaa, was used immediately for autolysis measurements. Factor
Xa, which, under normal conditions consists mainly of factor Xab, was
prepared for structural studies (CD or fluorescence) by incubating RVV
beads with factor X in buffer A with 5 mM Ca2þ for at least 90 min at room
temperature. Purified factor Xa was obtained by high-performance liquid
chromatography using a Mono Q column, as described for factor X. Factor
Xa concentration was determined from the rate of S2765 hydrolysis in
a plate-reader-based assay (Koppaka et al., 1996), using active-site-titrated
factor Xa (Jameson et al., 1973) to construct the standard curve.
DEGR-Xa preparation
DEGR-Xab and DEGR-Xaa were prepared by sequential addition of 5 mL
aliquots of DEGR-CK (;1 mg/ml in 0.02 M Tris-HCl, 0.1 M NaCl, pH 7.5
buffer) to 1.0 mL of factor Xab or factor Xaa at ;17 mM. The extent of
labeling at the active site was followed by the loss in enzymatic activity, as
monitored by the rate of S2765 hydrolysis. DEGR-CK addition continued
until no activity remained. DEGR-Xa was then dialyzed in buffer A to
remove free reagent (Husten et al., 1987) and analyzed by SDS-PAGE and
detected with a Foto/Prep II transilluminator (VWR Scientific, Norwalk,
CT) and with Coomassie blue to confirm that the probe was associated with
factor Xa.
Kinetic measurements of factor Xa autolysis
Several samples containing 6.5 mM factor Xaa but different concentrations
of lipid were followed simultaneously. Each sample was brought to 5 mM
in CaCl2 to start the reaction. Aliquots (15 mL) were removed from
each sample at different times into preprepared SDS-sample buffer and
then immediately heated for ;2 min at 1008C. A Multichannel Digital
Finnpipette (Labsystems, Finland) was used to add calcium to or remove
samples from the reaction mixtures to assure that reaction times were
carefully coordinated. The relative amounts of factors Xaa and Xab were
obtained from the relative intensity of the corresponding SDS-PAGE gel
bands measured on a scanning densitometer (Mitsubishi Model SLR-2D/1D,
Fotodyne, Cyprus, CA).
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Fluorescence measurements
The fluorescence intensity of DEGR-Xa was recorded at 228C with an
SLM 48000 fluorescence spectrophotometer (SLM Aminco, Rochester,
NY), using an excitation wavelength of 340 nm (band pass 8 nm) and
emission wavelength of 550 nm (4-nm band pass). Slits were kept closed
except during measurements to avoid photodegradation of the sample.
Before each titration, DEGR-Xa was incubated in buffer A with Ca2þ for
;20 min. Short-chain phospholipids were added in 2 or 3 mL aliquots, with
a maximum dilution of 4%. To correct for dilution, we measured the
emission intensity of DEGR-Xa in response to titration by buffer A.
Fluorescence intensity was recorded ;2 min after each addition. For each
lipid, several parallel measurements were performed and results were
averaged.
Data were analyzed according to the binding models described in the
Appendix. Nonlinear least squares fitting was accomplished using
SigmaPlot (version 4.0 for Windows; Jandel Scientific). We judged the
relative appropriateness of different models for describing each data set by
comparing the correlation coefficients of the fit (R2) and the sample
variances (s) using an F-test (Bevington, 1969). R2 is the adjusted square of
the correlation coefficient; values close to 1 indicate that the model provides
a good description of the variation of the dependent variable with the
independent variable. s is the ‘‘standard error of the estimate’’ or ‘‘sample
variance’’ (the square root of the quantity, sum of squared residuals divided
by the number of degrees of freedom). It gives a measure of the variability of
the data about the regression plane. A smaller value means a better fit of the
regression equation to the parent data set (Bevington, 1969).
Intrinsic fluorescence of factor Xa was recorded at 228C while exciting at
285 nm with an 8-nm excitation band pass on the SLM 48000 fluorescence
spectrophotometer. Scans were collected from 310 to 390 nm in ratio mode
and corrected for instrumental response. Scans of buffer or buffer plus C6PS
were recorded and subtracted from scans obtained with factor Xa to correct
for background scatter.
Effect of phospholipids on factor Xa activity
The amidolytic activity of factor Xa in the presence of soluble phospholipids
and Ca2þ was determined using the synthetic substrate S2765 (0.49 mM)
and a microplate reader (SLT 340 ATTC; SLT Instruments, Hillsborough,
NC), as described previously (Koppaka et al., 1996). The buffer was
a modified form of buffer A containing 0.6 wt % poly(ethylene glycol) to
prevent factor Xa from adsorbing to the plate. The effect of C6PS on factor
Xa amidolytic activity has been shown previously to be independent of
substrate concentration up to 1 mM, allowing us to conclude that the effect
of C6PS was not due to C6PS binding to substrate (Koppaka et al., 1996).
Circular dichroism measurements
CD spectra were recorded from 250 to 200 nm on an Aviv Model 620S
spectrometer (Aviv Associates, Lake Wood, NJ) in a 1-cm pathlength cell at
258C with a bandwidth of 1 nm. Samples were prepared in buffer B (1.2 mM
Tris, 150 mM NaCl, pH 7.4). Because correlating structural and functional
changes was our goal, we adopted this buffer to maintain a similarity to
buffer A used in activity and fluorescence measurements. When we collected
spectra in a very low-salt, Naþ-free buffer down to 185 nm, the effects of
Ca2þ and C6PS seen in physiological buffer could not be reproduced
(Srivastava and Lentz, unpublished observations). This probably reflects the
documented linkage between Naþ and Ca2þ binding to factor Xa (Rezaie
and He, 2000; Underwood et al., 2000) and the influence of Ca2þ on C6PS
binding (Koppaka et al., 1996). Because a buffer with physiological ionic
strength is not very transparent in the deep UV, this precluded complete
secondary structure analysis that requires data down to 185 nm, although
estimates of a-helix content could be made based on spectra collected to 200
nm (Johnson, 1990). Data points were collected every 0.5 nm with a 5-s
average time for each point. The digital data were processed, smoothed,
baseline-corrected, and converted to molar ellipticity, [Q]. For baseline
corrections, CD spectra were collected for C6PS, C6PG, and C6PC in buffer
with the same concentrations as for sample titration in the presence or
absence of Ca2þ. All buffer-corrected spectra were flat with roughly zero
molar ellipticity from 245 to 250 nm except at high short-chain lipid
concentration when this portion of the spectrum dipped dramatically. The
lipid concentration range in which this happened for C6PS was shown by
quasi-elastic light scattering (QELS) to correspond to the C6PS critical
micelle concentration (CMC) (Koppaka et al., 1996). Because the pro-
teolytic activity of factor Xa abruptly increased by 1.7-fold at the C6PS
CMC (Koppaka et al., 1996), it is clear that factor Xa binds to C6PSmicelles,
and we did not attempt to analyze data at or above the CMC of any of the
lipids examined.
Native gel electrophoresis to estimate the
molecular weight of factor Xa
Polyacrylamide gels were prepared at four different percentages of cross-
linking (5%, 6%, 8%, and 10%). Factor Xa and known marker proteins (270
kDa–14.2 kDa; Sigma, St. Louis, MO) were run on these gels in a BioRad
Mini-Protean II minigel apparatus (Biorad Corp., Hercules, CA) and stained
with colloidal Coomassie blue (Mitra et al., 1994). The Rf of each protein in
each gel was measured relative to the tracking dye. For each protein, a plot of
log (Rf3 100) against the percent gel concentration gave a straight line, the
negative slope of which is the retardation coefficient (Ferguson, 1964). A
log-log plot of the retardation coefficient against the molecular weights of
the marker proteins produces a linear curve from which the molecular weight
of any unknown protein may be determined (Bryan, 1977).
RESULTS
Response of bovine DEGR- Xa to C6PS,
C6PG, and C6PC parallels response
of human DEGR-Xa
One purpose of this paper was to confirm that responses of
bovine factor Xa to C6PS are due to structural changes.
Because many of our previous studies were performed with
human factor Xa, we focus first on demonstrating the
essential equivalency of the bovine and human forms of
factor Xa in their reactions to short-chain lipid binding.
Addition of C6PS to bovine DEGR-Xa, preincubated with
5 mM Ca2þ, led to a saturable decrease in emission intensity
that paralleled changes observed with human factor Xa
(Banerjee et al., 2002a) and indicated a change in the en-
vironment of the dansyl moiety at the active site (Fig. 1 A,
ﬁlled circles). Titration of bovine DEGR-Xa with PS/POPC
(1/3) membranes produced a 55% drop in DEGR-Xa fluo-
rescence (data not shown), consistent with but roughly twice
that seen with C6PS and consistent with a literature report
(Husten et al., 1987).
The discontinuity that occurs in the intensity of bovine
DEGR-Xa between 700 and 800 mM C6PS corresponds to
the CMC (800 mM) observed for C6PS at 5 mM CaCl2 in the
presence of 5 nM human factor Xa (Koppaka et al., 1996).
The discontinuity observed at 5 mM Ca2þ was not observed
at lower Ca2þ concentrations (Fig. 1 B), because the C6PS
CMC increases dramatically with increasing Ca2þ concen-
trations (Koppaka et al., 1996). Because factor Xa binds to
C6PS micelles above the CMC (Koppaka et al., 1996),
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titration curves were fit to binding models only for lipid
concentrations below the CMC.
Because of its S-shape, the C6PS binding isotherm was
not well described by a single-site-binding model (R2/s ¼
0.98/0.0086; Fig. 1, dotted curve). However, a cooperative
model that assumes two linked sites having equivalent
structural responses (Klotz and Hunston, 1975) was, as
expected, able to reproduce the S-shape of the binding
isotherm (fit not shown; stoichiometric dissociation con-
stantsKd1; 10.7 mM,Kd2; 14mM;R2/s¼ 0.998/0.0034).
Because the C6PS CMC is 1.5 mM in the presence of factor
Xa and 3 mM Ca2þ (Koppaka et al., 1996), we were able to
obtain data up to higher concentrations of C6PS at 3 mM
Ca2þ (Fig. 1 B, squares), making the failure of the single-
site-binding model especially clear (dotted curve; R2/s ¼
0.97/0.0097). Just as for human factor Xa (Koppaka et al.,
1996), C6PS binding was much less tight at Ca2þ
concentrations below 3 mM (Fig. 1 B). In the absence
of Ca2þ, the fluorescence of DEGR-Xa (Fig. 1 B, ﬁlled
diamonds) increased in response to C6PS, as we have
observed for human DEGR-Xa (Banerjee et al., 2002a).
This increase was well described by a single site model
(Fig. 1 B, dotted curve through ﬁlled diamonds ) with a kd
of 200 6 17 mM and a DRsat of 0.047 6 0.001.
Although we did not examine all the short-chain lipid
analogs that we did for human factor Xa, we did consider
responses to C6PG and C6PC. The response of DEGR-Xa
fluorescence to titration with C6PG at 5 mM Ca2þ (Fig. 1 C,
ﬁlled circles) shows that this lipid binds to bovine factor Xa
and elicits a sigmoidal response, as it does with human
DEGR-Xa (Banerjee et al., 2002a). No discontinuity was
detected in the titration of DEGR-Xa with C6PG, inasmuch
as the C6PG CMC at 5 mM Ca2þ in the absence of protein is
much larger (;14 mM) than that of C6PS (0.95 mM)
(Koppaka et al., 1996). In the absence of Ca2þ, C6PG
produced a positive change in DEGR-Xa fluorescence (Fig. 1
C, diamonds), although this change was so small (DRsat ¼
0.0106 0.001) that the apparent kd for this interaction could
not be determined with certainty.
The response of DEGR-Xa to C6PC at 5 mM Ca2þ (Fig. 1
C, closed triangles) was qualitatively different from the
response to either C6PS or C6PG in that there was no
sigmoidal shape to the titration curve, and C6PC caused
a slight increase rather than a decrease in emission intensity.
The C6PC CMC under these conditions is;9 mM (Koppaka
et al., 1996). The dotted curve drawn through these data
represents the best fit of the data to a single-site-binding
model, which yielded a kd of 436 6 160 mM and a DRsat of
0.0256 0.003. The response to C6PC in the absence of Ca2þ
also fit a single-site binding model (dotted curve though the
open triangles in Fig. 1 C) with similar binding parameters
(kd¼ 1506 18 mM; DRsat¼ 0.0226 0.004. It is clear from
Fig. 1 that the responses of DEGR-Xa to C6PS, C6PG, and
C6PC were qualitatively the same in the absence of Ca2þ and
similar to the response of C6PC in the presence of Ca2þ (Fig.
1 C, closed triangles), although the asymptotic fluorescence
changes associated with C6PS, C6PG, and C6PC binding in
the absence of Ca2þ were all different. Human Xa showed
the same behavior (Banerjee et al., 2002a).
Effect of short-chain phospholipid on bovine
factor Xa amidolytic activity
We reported previously that both soluble C6PS and
membrane-associated PS inhibited amidolytic activity of
human factor Xa to a comparable extent (Fig. 6 of Koppaka
et al., 1996). To assure that the bovine protein had a
functional response to C6PS similar to that of the human
protein, we report in Fig. 2 the amidolytic activity of bovine
factor Xa (relative to the activity in the absence of C6PS) as
a function of C6PS concentration in the presence (triangles:
FIGURE 1 (A) DEGR-Xa (ﬁlled circles) at 100 nM in buffer A (50 mM
Tris, 0.1 M NaCl, pH 7.5) was titrated at 228C with C6PS in the presence of
5 mM Ca2þ. Fluorescence intensities were measured 2 min after addition of
lipid. Fit to the single-site model (Eq. 1) (dotted lines) and the sequential-
linked-site model (Eq. 1) (solid line) are shown. Parameters resulting in
these fits are given either in the text or in Table 1. (B) DEGR-Xa (100 nM) in
buffer Awas titrated with C6PS in the presence of 3 mM (squares) and 1mM
(inverted triangles) CaCl2 and in the absence of CaCl2 (diamonds). Fits to
the data are as described in A. (C) DEGR-Xa (100 nM) in buffer A was
titrated with C6PG (ﬁlled circles) and C6PC (ﬁlled triangles) in the presence
of 5 mM Ca2þ; with C6PG in the presence of 1 mM (ﬁlled inverted
triangles) Ca2þ or no Ca2þ (ﬁlled diamonds); with C6PC in the absence of
Ca2þ (open triangles). Fits to the data are as described for A.
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2 mM; circles: 5 mM) and in the absence (squares) of Ca2þ.
As for human factor Xa (Koppaka et al., 1996), the
amidolytic activity of bovine factor Xa was inhibited by
C6PS. The site dissociation constant (98 mM) obtained from
a least-squares fit of the 5 mM Ca2þ data to a single-site
model is somewhat higher than we have reported for C6PS
effect on human factor Xa (67 mM) (Koppaka et al., 1996).
Binding was weaker at lower Ca2þ concentrations (kd  190
mM at 2 mM Ca2þ), as also seen for the human protein
(Koppaka et al., 1996). In the absence of Ca2þ, C6PS had no
effect on activity of either the bovine or human protein.
Effect of soluble phospholipids on the rate
of factor Xaa autolytic activity
Bovine factor X can be activated by two alternative pathways
(Fujikawa et al., 1974; Jesty et al., 1974, 1975). The first is
initiated by the action of factor VIIa or RVV on factor X to
cleave an activation peptide from the amino terminus of the
heavy chain to produce factor Xaa. Factor Xaa is then con-
verted autocatalytically to factor Xab with the loss of a 17-
residue glycopeptide from the carboxy terminus of the heavy
chain. The conversion of factor Xaa to factor Xab is lipid de-
pendent. The alternative pathway is initiated by the action of
factor Xa on factor X in the presence of lipid to produce
factor Xab.
Fig. 3 shows the time course of the appearance of factor
Xab due to autolysis of factor Xaa, as monitored by SDS-
PAGE in the presence of 5 mM CaCl2 and various
concentrations of soluble phospholipids or membranes.
The fraction of factor Xa in the b (autolyzed) form was
estimated from intensities of SDS-PAGE gel bands (gels not
shown). Of the three short-chain lipids examined (C6PC,
closed circles; C6PG, ﬁlled inverted triangles; C6PS, ﬁlled
triangles), only C6PS produced a significant enhancement
($70-fold) in the rate of factor Xaa autolysis relative to the












C6PS Sequential kd1 90y 90y 110 6 15 90y
2/A4 kd12 222 6 34 682 6 185 1420z 255 6 22
DRsat,1 0.06 6 0.02 0.02z 0.19 6 0.01 0.04 6 0.01
DRsat,12 0.28 6 0.01 0.41 6 0.04 0.060z 0.36 6 0.01
R2/s 0.997/0.0042 0.997/0.0053 0.993/0.0042 0.999/0.0036
Dimer/Seq. kd1 90y 90y ND 90y
2/A6 kd12 208 6 39 435 6 137 185 6 26
DRsat,1 0.14z 0.11z 0.15z
DRsat,12 0.30 6 0.01 0.37 6 0.04 0.35 6 0.01
DRsat,3 0.16z 0.13z 0.16z
R2/s 0.998/0.0036 0.996/0.0044 0.999/0.0031
C6PG Sequential kd1 200y 200y NA NA
2/A4 kd12 1130 6 270 750 6 110
DRsat,1
§ 0.013z 0.023 6 0.008
DRsat,12
§ 0.18 6 0.02 0.16 6 0.01
R2/s 0.988/0.004 0.994/0.0015
*Units of dissociation constants are mM. DRsat values are fluorescence quantum yield differences between the lipid-bound state and the lipid-free state of
DEGR-Xa relative to the quantum yield of the lipid-free state.
yThis value fixed based on titration of activity for C6PS or results 6Ca2þ for C6PG.
zA t-test on this parameter produced a P . 0.05%, where P is the probability of being wrong in concluding that the parameter is zero. This indicates that this
parameter value is ill determined.
§These parameter values were constrained such that DRsat,1 . 0, DRsat,12 , 0.
ND (not determined).
NA (not applicable) means that these data did not support this analysis.
FIGURE 2 Relative rates of S-2765 hydrolysis by bovine factor Xa
(5 nM) as a function of C6PS in the presence of 5 mM Ca2þ ( ﬁlled circles),
2 mM Ca2þ ( ﬁlled triangles), and in the absence of Ca2þ ( ﬁlled squares)
were determined at 378C in a buffer containing 50mM Tris, 175 mM NaCl,
0.6% PEG, at pH 7.6. The data are expressed as a fraction of the rate of
S2765 hydrolysis by factor Xa in the absence of C6PS. The lines indicate the
fits of the data to a model assuming a single C6PS site on factor Xa, yielding
dissociation constants of 190 and 98 mM in the presence of 2 and 5 mM
Ca2þ, respectively.
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rate in the absence of lipid (open diamonds). This rate
enhancement occurred below the CMC for C6PS observed in
the presence of factor Xa (0.8 mM (Koppaka et al., 1996)).
At or above the CMC, C6PS micelles induced an even
greater increase (from $170- to 230-fold) in the rate of Xaa
autolysis (0.8 mM C6PS, ﬁlled squares; 1.36 mM, ﬁlled
diamonds). The rate enhancement of factor Xaa autolysis by
C6PS is contrasted in Fig. 3 to the rate enhancement induced
by PS/POPC (1/3) membranes (220-fold; open circles).
Clearly, the largest part of the autolysis rate enhancement in
the presence of a PS-containing membrane is due to the PS
molecule, but there is roughly a two- to threefold increased
rate due to the presence of an interface, be it a membrane or
micelle interface. These data agree with the 60-fold increase
in proteolytic activity that we have reported (Koppaka et al.,
1996) for the effect of C6PS on the proteolytic activity of
human factor Xa against prothrombin and show conclusively
that the effect of C6PS is on factor Xa and not on its substrate
prothrombin. They also agree with our finding for human
factor Xa that the effect of a PS membrane or micelle surface
is only two- to threefold greater than the effect of C6PS in
solution (Banerjee et al., 2002b). DOPG/POPC membranes
(open squares) did enhance the reaction rate by 18-fold, but
the rate was much lower than that observed in the presence of
soluble or membrane-associated PS. POPC membranes
produced only a fivefold increase in the rate of factor Xa
autolysis (open triangles).
In summary, both active-site-labeled bovine DEGR-Xa
and unlabeled bovine Xa respond to different soluble lipids
in a fashion analogous to the response of the human protein,
except that lipid binding to the human protein was in general
a bit tighter than was binding to the bovine protein. The re-
sponse of factor Xa activity to C6PS was hyperbolic whereas
that of DEGR-Xa fluorescence was sigmoidal in shape.
C6PS triggers factor Xa dimerization
To test the possibility that the difference in structural and
functional responses might be that these experiments were
performed at very different factor Xa concentrations (100 nM
for fluorescence and 5 nM for activity measurements), we
titrated 1 nM DEGR-Xa in the presence of 5 mM Ca2þ with
C6PS. The response was no longer sigmoidal (Fig. 4, open
triangles). Nor was it simply hyperbolic, inasmuch as a
single-site model could not describe the data either, as seen
from the dotted curve drawn through the triangles in Fig. 4.
The difference in response of DEGR-Xa to C6PS at 1 and
100 nM DEGR-Xa might be an artifact associated with
pressing the limits of sensitivity of our fluorometer at 1 nM
DEGR-Xa. To test for this possibility, we performed
a titration at yet a third DEGR-Xa concentration (150 nM).
FIGURE 3 Fractions of factor Xa present as factor Xab were obtained
from quantitative densitometry of SDS-PAGE gels (not shown) and are
plotted as a function of time of incubation at 228C with different lipids: 0.43
mMC6PS ( ﬁlled triangles); 0.8 mMC6PS ( ﬁlled squares); 1.36 mMC6PS
( ﬁlled diamonds); 1 mM C6PG ( ﬁlled inverted triangle); 1 mM C6PC
( ﬁlled circle); 1 mM DOPG/POPC membranes (open squares); 1 mM
POPS/POPC membranes (open circles); 1 mM POPC membranes (open
triangles); and no lipid (open diamonds).
FIGURE 4 DEGR-Xa at 1 nM (open triangles) and 150 nM (open circles)
in buffer A (50 mM Tris, 0.1M NaCl, pH 7.5) was titrated with C6PS in the
presence of 5 mM Ca2þ, at 228C, as described for Fig. 1. The response of
DEGR-Xa fluorescence to C6PS titration in the absence of Ca2þ is also
shown for 1 nM (open diamonds) and 100 nM (closed diamonds) protein.
Lines drawn through the data show fits as described in Fig. 1.
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The resulting response curve (Fig. 4, open circles) showed
a clear sigmoid shape but differed in the magnitude of the
response from data obtained at 100 nM factor Xa (compare to
Fig. 1 A). Clearly, the response to C6PS varied with protein
concentration, suggesting that factor Xa might self-associate,
at least under the influence of C6PS, and that self-association
might influence the observed response to C6PS.
To test for possible C6PS-induced factor Xa self-
association, we recorded factor Xa intrinsic fluorescence
spectra as a function of protein concentration, in the presence
and absence of 600 mM C6PS and/or 5 mM Ca2þ (data not
shown) and found complex changes in intrinsic fluorescence
with increasing factor Xa concentration. In Fig. 5, we pre-
sent the intensity of the Trp peak of factor Xa intrinsic
fluorescence as a function of factor Xa concentration. Not
surprisingly, the intensity of factor Xa alone increased lin-
early with factor Xa concentration in the presence (frame A,
closed circles) and absence (frame C, closed squares)
of Ca2þ. Even in the presence of C6PS, the intrinsic
fluorescence increased in a linear fashion in the absence of
Ca2þ (Fig. 5 C, closed inverted triangle). However, the
fluorescence intensity in the presence of both Ca2þ and C6PS
increased in a saturable fashion and then increased linearly
with factor Xa concentration (Fig. 5 B, ﬁlled triangle). The
linear increase of fluorescence represented by the straight
line in Fig. 5 B was subtracted from the whole curve in this
frame, and the saturable residual curve is shown in the inset
to Fig. 5 B. These data were fit to a dimerization model (Eq.
2 in Appendix) to yield a dimer dissociation constant of 20
nM. Similar experiments were performed at several Ca2þ
concentrations with the resulting dimer dissociation con-
stants shown as a function Ca2þ concentration in Fig. 6 A.
The response of human factor Xa activity to C6PS, which is
dominated by binding to site 1 (Banerjee et al., 2002a),
shows a very similar Ca2þ dependence (Koppaka et al.,
1996). Fig. 6 B shows the variation of dimer association
constants with C6PS concentration. A hyperbolic fit to this
curve gave an apparent Kd of 96 mM, the same Kd obtained
for site 1 (Kd  98 mM, Fig. 2). Thus, both the Ca2þ- and
C6PS-dependences of dimerization indicate that occupancy
of site 1 site triggers dimerization.
To obtain a direct measure of factor Xa self-association
under a variety of conditions, native polyacrylamide gel
electrophoresis was performed. A sample 7% gel is shown as
an inset to Fig. 7 and demonstrates that both monomer and
dimer were easily resolved. No higher order aggregates were
observed at the stacking/running gel interface of any
experiment (Fig. 7, top of gel ). From these gels, the
retardation coefficient of each protein was obtained as
FIGURE 5 The intrinsic tryptophan fluorescence intensity of factor Xa
recorded at 344 nm is plotted as a function of factor Xa concentration in the
presence of Ca2þ (A, closed circle) and in the absence of 5 mM Ca2þ in the
presence (closed inverted triangle) and absence (closed square) of 600 mM
C6PS (C). (B) Factor Xa intrinsic fluorescence intensity is plotted as
a function of factor Xa concentration in the presence of 650 mM soluble
C6PS (closed triangle). The lower inset to B shows the data in this frame
with the limiting linear increase of fluorescence intensity (line through the
data at higher Xa concentrations) subtracted. When these data were fit to
a simple dimerization model (see text), a dimerization kd of ;20 nM was
obtained.
FIGURE 6 Dependence of Xa dimerization on experimental conditions.
(A) The variation of the dissociation constant (kddimer) of bovine factor Xa
with Ca2þ concentration at 600 mM C6PS. (B) A plot of dimer association
constant Kdimer versus C6PS concentration at 5 mM Ca2þ. A fit of these
values to a hyperbolic curve gave an apparent C6PS kd of 96 mM with
Kd
dimer
sat ¼ 17.2 nM.
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described in Methods. Fig. 7 shows a plot of log (retardation
coefficient) versus log (molecular weight) (Ferguson, 1964)
for four marker proteins ( ﬁlled circles) and 100 nM factor Xa
in the absence of Ca2þ( ﬁlled triangle; 47 6 1.5 kDa). The
molecular mass of bovine factor Xa is reported by amino acid
and carbohydrate analysis to be 45 kDa (Jesty and Nemer-
son, 1976). In the presence of 400 mM C6PS, the molecular
mass of factor Xa was 114 6 1.7 kDa at 5 mM Ca2þ (Fig. 7,
star). From the ratio of these molecular masses (2.4), it
seems most likely that factor Xa forms a dimer in the
presence of soluble C6PS, with the shape of the dimer
causing it to run at slightly greater than twice the molecular
mass of the monomer. The fraction of factor Xa involved in
dimer under these conditions was 85% (calculated from the
dimerization constant recorded in Fig. 6 and obtained as in
Fig. 5), whereas the fractions of material in the dimer and
monomer bands of lane 4 of Fig. 7 were found from
densitometry to be 83 and 17%, respectively. The fact that
the distribution of material in the gel reflects the equilibrium
distribution in solution suggests that dissociation is slow. It
also provides direct validation of our use of intrinsic
fluorescence to obtain dimerization constants. A gel run in
the presence of 400 mM C6PS but at 1 nM FXa showed that
only monomer with a molecular mass of 46 6 1.6 kDa (data
not shown) existed under the conditions of the open triangles
in Fig. 4. A control experiment with 100 nMXa, 2 mMCa2þ,
and 100 nM Xa showed a monomer (Fig. 7, diamond) of 47
6 0.8 kDa, verifying the Ca2þ-dependence of factor Xa
dimerization shown in Fig. 6 A. Finally, an experiment
performed at 5 mM Ca2þ with 400 mM C6PC and 100 nM
Xa also showed only monomer Xa (data not shown),
demonstrating the specificity of C6PS-induced dimerization.
Sedimentation velocity experiments have shown bovine
factor Xa to be a 45 kDa monomer in solution in the presence
of Ca2þ (Pryzdial and Mann, 1991). Our results agree with
this, but clearly show that factor Xa dimerizes in the presence
of C6PS.
We conclude that bovine factor Xa forms a dimer under
the influence of C6PS binding to site 1 and that the different
responses seen for titration of DEGR-Xa fluorescence at 100
and 1 nM factor Xa probably reflect different structural
responses elicited by C6PS from the two aggregation states
of factor Xa. Thus, binding of C6PS to bovine factor Xa alters
its activity, active site environment, and aggregation state
in solution. This strongly implies a structural change, the
possibility of which we address next with a direct structural
measurement.
Effects of short-chain phospholipids on factor
Xa secondary structure
CD specta of factor Xa at various concentrations of soluble
lipids (Fig. 8) are notable for their lack of a pair of negative
peaks at 208 and 222 nm that characterize a-helical
secondary structure (Johnson, 1990). Instead, the spectrum is
dominated by a single negative band whose peak varies
from 203 to 206 nm, depending on the presence of Ca2þ and/
or C6PS. This implies that factor Xa in solution consists
mainly of b-structures and little a-helix, as confirmed by
spectral analysis (Sreerama andWoody, 2000) (11% a-helix,
with and without Ca2þ). Of course, analysis of these spectra
taken only to 200 nm could yield no useful information
about b-or disordered structures (Johnson, 1990). However,
analysis of spectra carefully collected to 185 nm in salt-
free buffer confirmed the presence of only 11% a-helix, with
b-structures (sheets and turns) accounting for 60% of the
FIGURE 7 Factor Xa was analyzed by native
polyacrylamide gel electrophoresis in buffer A
plus 5 mM CaCl2 as described in Methods.
Retardation coefficient for different reference
proteins were obtained from plots of log Rf
versus percent cross-linking (5%, 6%, 8%, and
10%). A log-log plot of retardation coefficient is
shown for these reference proteins (closed
circles). Points have been added to this plot for
retardation coefficients obtained for 100 nM
factorXawith 5mMCa2þ in the absence (closed
triangle) or presence (closed star) of 400 mM
C6PS and also with 2 mM Ca2þ and 400 mM
C6PS (closed diamond). The inset shows lanes
from the 7% gel (lane 1—markers, lane 2—100
nM Xa with 2 mM calcium and 400 mM C6PS,
lane 3—100 nM Xa with 5 mM Ca2þ without
C6PS, lane 4—100 nMXa with 5 mMCa2þ and
400mMC6PS)with bandsnotedby arrows from
thepointsontheFergusonplot (Ferguson,1964).
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spectral shape. Although the crystal structure of whole
bovine factor Xa has not been determined, the crystal
structure of the highly homologous human factor IXa has
13% a-helix and 23% b-sheet, with b-turns not tabulated
(from the Protein Data Bank based on Brandstetter et al.
(1995).
Because the major features of the spectra in Fig. 8 are
consistent with what information we have about the
secondary structure of factor Xa, we may use this approach
to monitor changes in factor Xa secondary structure asso-
ciated with binding of soluble lipids. Because we could not
obtain the deep UV spectra needed for a detailed secondary
structure analysis (Johnson, 1990), we used the ratio of
ellipticity at 222 nm to that at 208 nm (Q222/Q208)
(Greenfield and Fasman, 1969) as well as estimates of the
fraction of a-helix (Sreerama and Woody, 2000) to monitor
changes in secondary structure induced by binding of soluble
lipids.
Although the CD spectrum of factor Xa was slightly red-
shifted on addition of Ca2þ (compare solid lines in Fig. 8 B
to Fig. 8A), there was no significant change in theQ222/Q208
ratio (0.52 in both cases) or in our estimate of helical content
(11% in both cases). Fig. 8 A also shows that addition of 600
mM C6PC (dot-dot-dashed line), C6PG (dotted line), or
C6PS (dot-dashed line) to factor Xa in the presence of 3 mM
Ca2þ caused shifts in bovine factor Xa secondary structure.
All three lipids changed the shape of the CD spectrum. These
changes were clearly detectable both as reproducible
changes in the Q222/Q208 ratio at increasing concentrations
of C6PC (triangles), C6PG (squares), or C6PS (circles)
(Fig. 8 A, inset), and as changes in a-helical content (1,
þ2.8, and þ6%, respectively). These results are consistent
with the different changes in DEGR-Xa fluorescence seen for
the three different lipid species, in that C6PC- and C6PG-
induced different conformational changes in factor Xa, with
both of these different from the large changes induced by
C6PS. Because the Q222/Q208 ratio increased for all three
lipids, but the a-helical content decreased for C6PC, it is
clear that changes in the Q222/Q208 ratio reflected more than
just changes in helix content.
Fig. 8 B shows that the CD spectrum of factor Xa also
changed upon addition of C6PS, C6PG, and C6PC in the
absence of Ca2þ, but these soluble lipids induced different
conformational changes (inset) than seen in the presence of
Ca2þ, consistent with our DEGR-Xa titration results (Fig. 1).
As for the DEGR-Xa results, the response of factor Xa sec-
ondary structure to C6PC was the same in the presence
(Fig. 8 A, inset) or absence (Fig. 8 B, inset) of Ca2þ.
Inasmuch as C6PS induces dimerization in the presence of
Ca2þ, the changes observed in the presence of Ca2þ could
represent changes in secondary structure associated with
intermolecular structures formed upon dimer formation.
Even minimal conditions for CD experiments (2mM Ca2þ
and 200 nM Xa) will produce a small amount of dimer (;5–
7% of Xa from Fig. 6 B) when C6PS occupies site 1. It was
thus impossible to measure directly the effect of C6PS on the
CD spectrum of monomeric factor Xa without inducing some
dimer formation. Thus, we resorted to taking a series of
spectra under conditions that should result in decreasing
dimer formation. Spectra taken in the presence of 3 mM
Ca2þ and 600 mM C6PS, but at 300 and 200 nM factor Xa,
showed decreasing negative peaks at 208 nm (data not
shown). A spectrum taken at 5 mM Ca2þ, 600 mM C6PS,
and 600 nM factor Xa, for which even more Xa should be
dimer, had an even larger negative ellipticity minimum (data
not shown). From the factor Xa dimerization constant
observed at 3 and 5 mM Ca2þ and 600 mM C6PS (Fig. 6
A), we calculated the fraction of Xa involved in dimer
formation under these varying conditions and plot the Q222/
Q208 ratio as a function of this in the upper inset to Fig. 8 A.
The intercept of a straight line through these data predicts
FIGURE 8 (A) Factor Xa (0.6 mM) in buffer B (1.2 mM Tris, 150 mM
NaCl, pH 7.4) was examined at 248C in the presence of 3 mM CaCl2 (solid
line); and in the presence of 0.6 mM C6PS (dot-dash-dot line), C6PG
(dotted line), and C6PC (dot-dot-dashed line) with 3 mM CaCl2. (B) Factor
Xa (0.6mM) in buffer (1.2 mMTris, 150 mMNaCl, pH 7.4) was examined at
248C (solid line); and in the presence of 0.6 mM C6PS (dot-dash-dot line),
C6PG (dotted line), and C6PC (dot-dot-dashed line) in the absence of
CaCl2. In the lower insets to A and B, the effects of C6PS (circles), C6PG
(squares), and C6PC (triangles) concentrations on Q222/Q208 ratios
measured from CD spectra of factor Xa in the presence of 3 mM Ca2þ
(A) or in the absence of Ca2þ (B). The upper inset to A shows the variation
ofQ222/Q208 ratio with fraction of Xa present as dimer (obtained using kdimer
from the upper inset to Fig. 6 B) for factor Xa concentrations of 200, 300,
and 600 nM.
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that factor Xa monomer bound to C6PS in the presence of
Ca2þ would give a Q222/Q208 ratio of 0.44, nearly the same
value seen for monomer factor Xa at saturating C6PS con-
centration in the absence of Ca2þ (0.45; Fig. 8 B, inset). This
implies that the secondary structural change seen in response
to C6PS in the presence of Ca2þ results in part from dimer
formation and in part from a change in secondary structure
associated with C6PS binding to monomer factor Xa.
DISCUSSION
Both human and bovine factor Xa have two soluble-lipid-
binding sites, site 1 in the EGFNC domain pair that is Ca2þ-
dependent and site 2 in the catalytic domain that is Ca2þ
requiring and probably corresponds to part of a protein
recognition site rather than being a lipid regulatory site
(Srivastava et al., 2002). In addition, other studies of DEGR-
Xa fluorescence and factor Xa activity have shown that these
two sites in human factor Xa are linked, that they have
different minimal lipid specificities, and that site 1 is
principally involved in regulating factor Xa activity (Baner-
jee et al., 2002a). While these studies suggest that factor Xa
activity is regulated via structural changes induced by C6PS
binding, they provided no direct proof of C6PS-induced
protein structural changes. To demonstrate C6PS-induced
structural changes, we focused in the current paper on bovine
factor Xa, which is available more inexpensively in the large
quantities needed for structural work. The first part of the
results in this paper establish that bovine factor Xa behaves
analogously to human factor Xa with respect to C6PS
binding, making it reasonable to assign responses observed
for one of these very similar forms of factor Xa to the other.
The second part of this work leads to three significant
conclusions about the effect of PS molecules on bovine
factor Xa:
1. The two sites on bovine factor Xa differ in their response
to Ca2þ and to different lipid species. Site 1 is occupied
by C6PG and C6PC with similar affinity (kd; 200 mM)
in the presence or absence of Ca2þ but with higher
affinity by C6PS in the presence (kd; 90–100 mM) than
in the absence (kd; 200 mM) of Ca2þ. This is the EGFNC
site (Srivastava et al., 2002) that recognizes DAG as
a minimal ligand in human factor Xa (Banerjee et al.,
2002a). Site 2 does not bind C6PC and requires Ca2þ to
bind C6PS (kd; 160–250 mM) or C6PG (kd; 700–1100
mM). This site is in the catalytic-domain site (Srivastava
et al., 2002) and in human factor Xa recognizes GPS as
a minimal ligand (Banerjee et al., 2002a).
2. Description of C6PS or C6PG binding to these sites
minimally requires the sequential-linked-site model. The
requirement for something like this model derives from
the different response of DEGR-X fluorescence (sigmoi-
dal; Fig. 1) and factor Xa activity titration (hyperbolic;
Fig. 2) to C6PS, a situation that also exists for human
factor Xa (Banerjee et al., 2002a; Koppaka et al., 1996).
There is no way to justify these observations within the
context of the traditional linked-site model (Klotz and
Hunston, 1975) in which both sites respond with the same
structural or functional change. This is because assigning
a site dissociation constant (kd) of 90–100 mM (the
binding constant obtained from titration of factor Xa
activity, Fig. 2), and using published procedures for
calculating site constants from stoichiometric constants
with one site constant known (Klotz and Hunston, 1975)
led to physically unreasonable estimates of the other two
independent site dissociation constants for the interaction
of C6PS with factor Xa. The basic problem is that the fit
provided by the linked-site model requires that tight
binding should occur only once a weak site is occupied,
and this was not the behavior seen for the response of
activity to C6PS (Fig. 2). Because competitive and
cooperative binding experiments with different lipid
species demonstrate that the two lipid binding sites on
human factor Xa are linked (Banerjee et al., 2002a), we
have concluded that a more complex linked-site model is
needed to describe our data for C6PS binding to factor
Xa. The sequential-linked-site model described in the
Appendix is the simplest model that we have found
accounts for our observations. In fitting our data to this
model, we fixed the dissociation constant assigned to site
1 (90 mM), leaving three adjustable parameters, which,
for the most part, were well defined by the regression
process. This model provided an adequate description
of data at both low (1nM) and high (100 or 150 nM)
DEGR-Xa concentrations, as documented in Figs. 1 and 4
(solid lines) and Table 1. A likely explanation for the
simple hyperbolic response of factor Xa activity (Fig. 2)
is that occupancy of only one of the sites on factor Xa (the
first or EGFNC site) dominates the activity response but
that occupancy of both sites produces an increase in
activity, as demonstrated quantitatively for human factor
Xa (Banerjee et al., 2002a). Despite the empirical success
of this model, the behavior of factor Xa is clearly more
complex than it suggests. Thus, the model assumes that
the two sites are occupied sequentially to produce
different structural responses in the singly bound and
doubly bound species. However, we know that GPS can
weakly (kd  0.8 mM) occupy site 2, but that occupancy
is much tighter (kd  0.09 mM) if DAG occupies site 1
(Banerjee et al., 2002a). This means that the ‘‘sequential’’
aspect of our model is an approximation, but a reasonable
approximation that reduces the number of unknown
parameters from six to four (see Appendix). The
sequential-linked-site model is also an approximation in
that we show here that C6PS triggers Xa dimer formation
(Figs. 6 and 7), but the model does not take into account
dimerization. Thus, any response that we see to C6PS
includes structural responses of binding to monomer as
well as the consequences of dimer formation. Indeed,
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a possible interpretation of our DEGR-Xa fluorescence
data is that C6PS binding to site 1 in monomer Xa might
trigger conformational changes that expose the DEGR
probe to water (negative DEGR fluorescence change at
low DEGR-Xa concentration, Fig. 4 and Table 1), while
these same conformational changes might induce dimer
formation that then buries the DEGR probe at a dimer
interface (positive DEGR fluorescence change, Fig. 1 and
Table 1). At higher C6PS concentration, a negative
fluorescence change would dominate. To test this
interpretation, we formulated the dimer-sequential model
(Appendix) that allows for factor Xa bound to a single
molecule of C6PS to exist as either a monomer or a dimer.
This introduced another unknown parameter (the fluo-
rescence change associated with the C6PS-bound mono-
mer, DR1 in Eq. A3). The extra free parameter naturally
improved somewhat the fit to our data, but also led to
poorly determined saturating fluorescence changes for
each presumed species (see Table 1). Nonetheless, the
binding parameters that could be determined from
regression of this model to the data (kd1, kd12, and
DRsat,12) were consistent with the corresponding param-
eter values obtained using the linked-site, sequential
model (Table 1). Thus, while it is possible to explain our
results with more complex models that rely on dimer
formation, our data were insufficient to define the para-
meters associated with these models. We conclude that,
while this model provides a somewhat improved de-
scription of our data (an F-test comparing the fit variances
of the dimer-sequential and sequential-linked models
gave P  0.025) (P is the probability that the
improvement in fit is random rather than significant
(Bevington, 1969), the simpler sequential-linked-site
model catches the essence of factor Xa’s structural and
functional responses to C6PS titration without the need to
introduce an unreasonable number of adjustable param-
eters. This is expected to be true especially for [Xa] . 50
nM and [Ca2þ]. 3 mM, for which most Xa will be dimer
when site 1 is occupied.
3. Binding of C6PS to the first factor Xa lipid binding site
(EGFNC or DAG site) triggers conformational changes
that lead to factor Xa dimerization. Because dimer
formation accompanies occupancy of site 1, it is appro-
priate to comment on the evidence for C6PS-induced
structural change. First, the fluorescence decrease of
1 nM DEGR-Xa followed the sequential-linked-site
model,with decreases in fluorescence accompanying occu-
pancy of both C6PS sites (Table 1). In gel experiments
(Fig. 7), we confirmed that 1 nM factor Xa at 5 mM Ca2þ
did not form dimers, so that the changes in dansyl
fluorescence reflect changes in the active site environ-
ment of monomer factor Xa. Second, a secondary
structure change accompanied C6PS binding to site 1 in
the absence of Ca2þ (Fig. 8 B), when dimer formation is
not observed (Fig. 7). Third, C6PC also induced changes
in CD spectra in the presence and absence of Ca2þ (Fig.
8) even though C6PC does not promote dimer formation,
as we showed by native polyacrylamide gel. Finally,
while it is clear that some part of the structural response
seen to C6PS binding in the presence of Ca2þ is due to
dimerization (Fig. 8 A, upper inset), linear extrapolation
of our data to zero percent dimer yielded a Q222/Q208
equal to that induced by C6PS in the absence of Ca2þ
(see description of Fig. 8 A). These observations provide
broad support for our hypothesis that C6PS induces
conformational changes in factor Xa monomer that, in the
presence of Ca2þ, lead to dimerization, in itself an
indication of a structural change.
Are the effects of soluble C6PS due
to micelle formation?
Our conclusions depend on our results reflecting the effects
of individual C6PS molecules binding to factor Xa. We have
previously characterized by both probe fluorescence and
QELS the CMCs of C6PS, C6PC, and C6PG as a function
of Ca2þ concentration and in the presence of different
concentrations of factor Xa and prothrombin with and with-
out Ca2þ and 0.6 wt% poly(ethylene glycol) (Koppaka et al.,
1996). As documented throughout the Results section, we
were careful in this work never to analyze data taken at
concentrations above the CMC of the short-chain phospho-
lipid under study. We were able to detect micelle formation
both by QELS and by monitoring sudden changes in an
observable for each experiment as we went above the CMC
in C6PS concentration (see Results). The C6PS CMC ob-
tained in these different ways always agreed. Thus, the
results we report here reflect the binding of factor Xa to
soluble lipids, not to lipid micelles.
Aside from the possibility of micelle formation that our
controls rule out, Johnson et al. (1981) suggested that short-
chain C6PC may exist in an equilibrium mixture of
monomers and dimers below the CMC. Because of the net
negative charge on C6PS, this probably does not occur for
this short-chain lipid. However, if it did, binding of both
monomers and dimers of C6PS to a single site on factor Xa
might cause the observed sigmoidal binding behavior. This
possibility can be precluded for several reasons. First, the
binding of C6PC to DEGR-Xa showed no such behavior
(Fig. 2 A, ﬁlled triangles), although C6PC is the lipid
actually suggested to form dimers below its CMC (Johnson
et al., 1981). Second, the responses of amidolytic (Fig. 3) and
proteolytic activities of factor Xa (Koppaka et al., 1996) to
soluble lipids showed simple hyperbolic, not sigmoidal,
responses to C6PS. This can be explained easily in terms of
single C6PS molecules binding to and eliciting different
responses from two different sites, but is hard to explain in
terms of C6PS binding as a monomer or dimer to a single
site. Finally, direct equilibrium dialysis measurements show
that, while two soluble C6PS molecules bind to factor Xa
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(Banerjee et al., 2002a), they bind to different regions of the
factor Xa molecule (Srivastava et al., 2002). These measure-
ments are unequivocal and are inconsistent with our results
being due to binding of C6PS dimers to factor Xa.
Relationship of C6PS binding sites
to membrane binding
Binding of prothrombin and factor Xa to membranes has
been well studied. The Gla domain is required for the Ca2þ-
dependent interaction with phospholipid membranes (Hen-
riksen and Jackson, 1975), and a comparison of binding
affinity does show that the Gla domain plus first Kringle
domain (termed fragment 1) of prothrombin account for
most, but not all, of the membrane-binding free energy
(Pearce et al., 1993). Several models for the mechanism of
membrane binding have been proposed: absorption to
clusters or domains of 10 or so acidic lipids in the plane of
the membrane (Lim et al., 1977; van Dieijen et al., 1981);
specific occupancy of a limited number (two–four) of PS
binding sites (Cutsforth et al., 1989; Tendian and Lentz,
1990); membrane insertion of a hydrophobic loop involving
residues 5 and 8 of the Gla domain (Christiansen et al., 1995;
Falls et al., 2001); or formation of a specific lipid-binding
pocket involving residues 11, 33, and 34 (McDonald et al.,
1997). While there remains controversy about the mecha-
nism of binding, the prevailing opinion is that membrane
binding involves a limited number of sites on factor Xa and
that the most significant contribution to the free energy of the
process derives from the Gla domain. If so, how can a PS site
in the EGFNC domain pair be important to membrane
binding? The answer is that this site is likely not a significant
contributor to the free energy of membrane binding but
rather accounts for the effects of PS-containing membranes
on factor Xa behavior. This follows from the fact that, for
every observable that was altered by C6PS, there was
a qualitatively similar (but not identical) change due to PS-
containing membranes. There was a 70-fold increase in
bovine Xa autolysis rate when C6PS was present and only
a two- to threefold additional increase in the presence of PS-
membranes (Fig. 3). C6PS decreased factor Xa amidolytic
activity by 55% (Fig. 2), while PS-containing membranes
decreased this activity by 35% (Koppaka et al., 1996).
Adding soluble C6PS produces a saturable 60-fold increase
in the rate of prothrombin activation (Banerjee et al., 2002b;
Koppaka et al., 1996), while the rate of prothrombin
proteolysis by human factor Xa (in the absence of factor
Va) increased by 475-fold at an optimal membrane con-
centration of 50 mM (Banerjee et al., 2002b; Wu et al.,
2002). However, a substantial fraction of this increase was
due to a membrane-surface effect: channeling of intermedi-
ate back to the enzyme for rapid conversion to thrombin
(Banerjee et al., 2002b; Wu et al., 2002). Finally, control
experiments showed that DEGR-Xa fluorescence decreased
by 55% upon addition of PS-containing membranes com-
pared to the 25% decrease seen with C6PS. A decrease in
human DEGR-Xa fluorescence upon titration with PS-
containing membranes has previously been interpreted in
terms of a membrane-induced change in factor Xa structure
(Husten et al., 1987), although, as we point out here, a change
in DEGR-Xa fluorescence is insufficient to demonstrate
a structural change. However, our results do demonstrate
C6PS-induced structural changes in factor Xa, and the
parallels between our measurements with C6PS and with PS-
membranes suggest that the decrease in DEGR-Xa fluores-
cence seen in the presence of PS-membranes reflects either
structural changes or dimerization, or both, induced by
membrane binding. Factor Xa dimerization on a PS-
membrane would likely have significant implications for
how membranes induce the interaction of factors Xa and
Va in vivo to form prothrombin-activating complex. This
deserves further study.
APPENDIX
Model for equilibrium binding of water-soluble
phospholipids to DEGR-Xa
If two ligand-binding sites are linked, and if their occupancy elicits different
structural responses, we can write for the net structural response an
expression that involves six unknown parameters. A simplification of this
model can be made when one site (second site) is unlikely to be occupied
without the other being occupied first. Making this assumption eliminates
two parameters. This is termed the sequential-linked-site model, and takes
the form:






where u ¼ 1þ ½Lk1 þ ½L2k1k12, R is the observed structural response, R0
is the value of R in the absence of ligand, DRsat,1 is the structural response to
occupancy of the first site, and DRsat,12 is the response to occupancy of both
sites. When the total protein concentration is much smaller than the ligand
concentration, [L] ﬃ [L]tot, modeling R as a function of [L] becomes much
easier. The quantity Q is a modified grand partition function describing the
distribution of ligands between sites on the protein. The sequential binding
model has four parameters: k1, k12, DRsat,1, and DRsat,12. For a protein with
a single binding site, k12 ¼ 0, and this expression reduces to the standard
single site binding model, which has only two free parameters, k1 and DRsat.
We had to consider one more model when we demonstrated that factor Xa
forms dimers in the presence of C6PS. It is easy to show that for a simple
dimerization reaction that produces a change in some observable, R, the





1þ 8kCp  1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 8kCp þ 1 ; (2)
where C is the total protein concentration, k is the dimer association
constant, whose lipid dependence is given in the legend to Fig. 6, andR0 and
Rsat are the values of the observable at limiting low and high protein
concentrations, respectively. If we presume that PS binding to a single site
enables dimer formation, then a fraction (f2) of the total concentration of the
species PL1 will be dimer and 1  f2 will be monomer. We represent the
response of the monomer as DRsat,1 and that of the dimer as DRsat,3 to
distinguish it from the response due to occupancy of the second site
(DRsat,12). We may then write:
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where we have replaced C in Eq. 2 with the concentration of protein bound
to a single PS, k13 [L]3PT. This makes f2 not only a function of PT, the
total protein concentration in an experiment, but also of the phospholipid
concentration added during a titration experiment. This is termed the dimer/
sequential binding model.
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